ASTHMA
Conditions
Interventions
none
Sponsors
Ishii Takeo
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1)Men and women aged >-20 years 2)Patients who have been diagnosed with asthma 3)Patients using ICS/LABA combination therapy for >-4 weeks 4)Patients with moderate or high MMAS status 5)Patients who are able to answer the questions through the website
Exclusion criteria
Exclusion criteria: 1)Patients using a biologic asthma medication 2)Patients who have been diagnosed with chronic obstructive pulmonary disease 3)Patients using long-acting muscarinic antagonist medication 4)Patients with a smoking history of >-10 years
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Health-related quality of life measured by AHQ-33 scores in all participants, the WC and NWC participant subgroups | — |
Secondary
| Measure | Time frame |
|---|---|
| 1)Distribution of Work Productivity and Activity Impairment:Asthma (WPAI:Asthma) scores in all participants, and the WC and NWC participant subgroups 2)Distribution of Leicester Cough Questionnaire (LCQ) scores in all participants, and the WC and NWC participant subgroups 3)Distribution of Description of the patient characteristics in all participants and by WC and NWC participant subgroups | — |
Contacts
Public ContactTakeo Ishii
GlaxoSmithKline K.K.
Outcome results
None listed